Variable | Details | ||
---|---|---|---|
Age at presentation | |||
Mean±SD | 43.7±14.0 years | ||
Median | 41 years | ||
Range | 24–81 years | ||
Gender, n (%) | |||
Male | 23 (92.0) | p<0.001* | |
Female | 2 (8.0) | ||
Laterality, n (%) | |||
Unilateral | 13 (52.0) | ||
Bilateral | 12 (48.0) | ||
Country of origin, n (%) | |||
Australia | 9 (36.0) | ||
Other | 14 (56.0) | ||
Unknown | 2 (8.0) | ||
Sexual orientation, n (%) | |||
Heterosexual | 12 (48.0) | ||
MSM | 8 (32.0) | ||
Unknown | 5 (20.0) | ||
Hospital admission, n | |||
Admitted | 16 | ||
Length of stay, median | 15.0 days | ||
HIV status, n (%) | |||
Positive | 8 (32.0) | ||
Negative | 12 (48.0) | ||
Unknown | 5 (20.0) | ||
HIV diagnosis, n | |||
Newly diagnosed | 3 | ||
Diagnosed within 5 years | 1 | ||
Diagnosed >5 years | 4 | ||
HIV treatment, n | |||
HAART at presentation | 2 | ||
Commenced on HAART | 2 | ||
CD4 count in HIV positive cases at presentation, cells/mm3 (six HIV positive cases had CD4 count recorded) | |||
Mean | 461 | ||
Range | 190–800 | ||
Syphilis stage†, n (%) | |||
Primary | 0 (0) | ||
Secondary | 0 (0) | ||
Early latent | 2 (8.0) | ||
Late latent | 6 (24.0) | ||
Unknown latent | 11 (44.0) | ||
Neurosyphilis | 6 (24.0) | ||
Systemic syphilis diagnosis, n (%) | |||
Syphilitic uveitis prompting new systemic syphilis diagnosis | 21 (84.0) | ||
Previous diagnosis of syphilis, presenting with uveitis | 4 (16.0) |
HAART, highly active antiretroviral therapy; MSM, men who have sex with men; n, number.
*χ2 test of significance.
†Syphilis stage classified according to the Centers for Disease Control case definitions 2012.14